World Health Organization （WHO）,Global Tuberculosis Report[OL],2014. Available：
[2]
Wang C,Yang S,Sun G,et al. Comparative miRNA expression profiles in individuals with latent and active tuberculosis [J]. PLoS One,2011,6（10）:e25832.
[3]
Maertzdorf J,Weiner J 3rd,Mollenkopf HJ,et al. Common patterns and disease-related signatures in tuberculosis and sarcoidosis [J]. Proc Natl Acad Sci U S A,2012,109（20）：7853-7858.
Fu Y,Yi Z,Wu X,et al. Circulating microRNAs in patients with active pulmonary tuberculosis [J]. J Clin Microbiol,2011,49（12）：4246-4251.
[6]
中华医学会. 临床诊疗指南 结核病分册[S]. 北京：人民卫生出版社,2005：7-9.
[7]
Ma F,Xu S,Liu X,et al. The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ [J]. Nat Immunol,2011, 12（9）：861-869.
[8]
Xiao B,Liu Z,Li BS,et al. Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response [J]. J Infect Dis,2009,200（6）：916-925.
[9]
Rathod SS,Rani SB,Khan M,et al. Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways [J]. FEBS Open Bio,2014,4：485-495.
[10]
Guo P,Lan J,Ge J,et al. miR-708 acts as a tumor suppressor in human glioblastoma cells [J]. Oncol Rep,2013,30（2）：870-876.
